Hirofumi Hirakawa, MD, PhD

Department of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan

  • 6Articles
  • 18.1KReads
  • 2015–2026Active
  • 10Collaborators
  • 7Citations

About

Hirofumi Hirakawa, MD, PhD is affiliated with Department of Neuropsychiatry, Oita University Faculty of Medicine, Yufu-city, Oita, Japan. Hirofumi Hirakawa has authored or co-authored 5 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2015 and 2025. Their work focuses on Schizophrenia/Schizoaffective Disorders, Cardiology, Depression (MDD), Neurology, and Seizures.

Publications

PCC
Peduncular Hallucinosis With Right Thalamic Cavernous Angioma
Case Report

Peduncular Hallucinosis With Right Thalamic Cavernous Angioma

August 18, 2026

A 56-year-old woman developed visual and auditory hallucinations, delusions of jealousy and possession, and cognitive impairment associated with a thalamic lesion
, ,
PCC
Clozapine-Induced Corrected QT-Interval Prolongation and Relationship With Serum Clozapine Concentration
Case Report

Clozapine-Induced Corrected QT-Interval Prolongation and Relationship With Serum Clozapine Concentration

December 18, 2025

The author presents a case of clozapine-induced QTc prolongation and discusses its relationship with serum clozapine concentration
PCC
Treatment Decision-Making Capacity With the MacCAT-T in Schizophrenia
Brief Report

Treatment Decision-Making Capacity With the MacCAT-T in Schizophrenia

June 1, 2023

This report is a narrative review of the studies on schizophrenia that evaluated both decision-making capacity for treatment with the MacCAT-T and severity of symptoms using a clinical rating...
JCP
Letter to the Editor

Depression as a Factor in Nonadherence in Schizophrenia

June 16, 2020

This letter comments on the article "Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia" by Kane and Correll.
,
PCC
Letter to the Editor

Bright Light Therapy for Negative Symptoms

September 7, 2017

Negative symptoms cause serious personal, social, and occupational functioning disability in schizophrenia patients. To date, the effect of bright light therapy on negative symptoms has been rarely studied, and...
, , , et al
PCC
Letter to the Editor

The Effects of Carbamazepine and Lithium Combination on Serious Aggression and Anger Outbursts in a Case of Seronegative Limbic Encephalitis

October 15, 2015

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe